No significant improvement in anterior knee pain with dextrose prolotherapy for Osgood-Schlatter
Arch Orthop Trauma Surg. 2020 Feb;140(2):197-202.Forty-nine knees with Osgood-Schlatter disease were randomized to receive three monthly injections of dextrose or normal saline for the improvement anterior knee pain. The outcome of interest was anterior knee pain, as measured on the Victorian Institute of Sport Assessment (VISA) score. Follow up occurred one, two and three months after the first injection took place. Results of the study revealed no significant differences in VISA scores between the dextrose group and normal saline group. Both groups reported significant improvements from baseline at all follow-up time-points.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
